Articles published by Adicet Bio, Inc.
![](https://www.businesswire.com/images/bwlogo_extreme.png)
![](https://mms.businesswire.com/media/20240628376872/en/1339314/22/adicet_logo_500x300_%28002%29_%28004%29.jpg)
![](https://mms.businesswire.com/media/20240624689420/en/1339314/22/adicet_logo_500x300_%28002%29_%28004%29.jpg)
Adicet Bio Announces FDA Clearance of IND Application for ADI-270 in Renal Cell Carcinoma
June 24, 2024
From Adicet Bio, Inc.
Via Business Wire
Tickers
ACET
![](https://www.businesswire.com/images/bwlogo_extreme.png)
![](https://mms.businesswire.com/media/20240531533860/en/1339314/22/adicet_logo_500x300_%28002%29_%28004%29.jpg)
![](https://mms.businesswire.com/media/20240529302537/en/1339314/22/adicet_logo_500x300_%28002%29_%28004%29.jpg)
Adicet Bio to Participate in a Fireside Chat at the 2024 Jefferies Healthcare Conference
May 29, 2024
From Adicet Bio, Inc.
Via Business Wire
Tickers
ACET
![](https://mms.businesswire.com/media/20240514582407/en/1339314/22/adicet_logo_500x300_%28002%29_%28004%29.jpg)
![](https://mms.businesswire.com/media/20240514346504/en/1339314/22/adicet_logo_500x300_%28002%29_%28004%29.jpg)
![](https://mms.businesswire.com/media/20240507737767/en/1339314/22/adicet_logo_500x300_%28002%29_%28004%29.jpg)
Adicet Bio to Participate in a Fireside Chat at the Citizens JMP Life Sciences Conference
May 07, 2024
From Adicet Bio, Inc.
Via Business Wire
Tickers
ACET
![](https://mms.businesswire.com/media/20240430855027/en/1339314/22/adicet_logo_500x300_%28002%29_%28004%29.jpg)
![](https://mms.businesswire.com/media/20240422828682/en/1339314/22/adicet_logo_500x300_%28002%29_%28004%29.jpg)
![](https://mms.businesswire.com/media/20240408693156/en/1339314/22/adicet_logo_500x300_%28002%29_%28004%29.jpg)
Adicet Bio to Participate in 2024 Canaccord Genuity Horizons in Oncology Virtual Conference
April 08, 2024
From Adicet Bio, Inc.
Via Business Wire
Tickers
ACET
![](https://mms.businesswire.com/media/20240328981961/en/1339314/22/adicet_logo_500x300_%28002%29_%28004%29.jpg)
![](https://mms.businesswire.com/media/20240319090811/en/1339314/22/adicet_logo_500x300_%28002%29_%28004%29.jpg)
Adicet Reports Fourth Quarter and Full Year 2023 Financial Results and Highlights Recent Company Progress
March 19, 2024
From Adicet Bio, Inc.
Via Business Wire
Tickers
ACET
![](https://mms.businesswire.com/media/20240311201028/en/1339314/22/adicet_logo_500x300_%28002%29_%28004%29.jpg)
![](https://mms.businesswire.com/media/20240229037082/en/1339314/22/adicet_logo_500x300_%28002%29_%28004%29.jpg)
Adicet Bio Reports Inducement Grant under Nasdaq Listing Rule 5635(c)(4)
February 29, 2024
From Adicet Bio, Inc.
Via Business Wire
Tickers
ACET
![](https://mms.businesswire.com/media/20240205899745/en/1339314/22/adicet_logo_500x300_%28002%29_%28004%29.jpg)
Adicet Bio to Participate in a Fireside Chat at the Guggenheim Healthcare Talks 6th Annual Biotechnology Conference
February 05, 2024
From Adicet Bio, Inc.
Via Business Wire
Tickers
ACET
![](https://mms.businesswire.com/media/20240131863785/en/1339314/22/adicet_logo_500x300_%28002%29_%28004%29.jpg)
![](https://mms.businesswire.com/media/20240125334899/en/1339314/22/adicet_logo_500x300_%28002%29_%28004%29.jpg)
![](https://mms.businesswire.com/media/20240122485713/en/1339314/22/adicet_logo_500x300_%28002%29_%28004%29.jpg)
Adicet Bio, Inc. Announces Pricing of Public Offering
January 22, 2024
From Adicet Bio, Inc.
Via Business Wire
Tickers
ACET
![](https://mms.businesswire.com/media/20240122038114/en/1339314/22/adicet_logo_500x300_%28002%29_%28004%29.jpg)
Adicet Bio, Inc. Announces Proposed Public Offering
January 22, 2024
From Adicet Bio, Inc.
Via Business Wire
Tickers
ACET
![](https://mms.businesswire.com/media/20240104790871/en/1339314/22/adicet_logo_500x300_%28002%29_%28004%29.jpg)
![](https://mms.businesswire.com/media/20240103490668/en/1339314/22/adicet_logo_500x300_%28002%29_%28004%29.jpg)
Adicet Bio to Host Conference Call to Provide Updates on its Clinical Pipeline and Corporate Outlook
January 03, 2024
From Adicet Bio, Inc.
Via Business Wire
Tickers
ACET
![](https://mms.businesswire.com/media/20231229199100/en/1339314/22/adicet_logo_500x300_%28002%29_%28004%29.jpg)
Adicet Bio Reports Inducement Grant under Nasdaq Listing Rule 5635(c)(4)
December 29, 2023
From Adicet Bio, Inc.
Via Business Wire
Tickers
ACET
![](https://mms.businesswire.com/media/20231210950496/en/1339314/22/adicet_logo_500x300_%28002%29_%28004%29.jpg)
![](https://mms.businesswire.com/media/20231108295662/en/1339314/22/adicet_logo_500x300_%28002%29_%28004%29.jpg)
![](https://mms.businesswire.com/media/20231107487145/en/1339314/22/adicet_logo_500x300_%28002%29_%28004%29.jpg)
Adicet Bio to Present at the 2023 Jefferies London Healthcare Conference
November 07, 2023
From Adicet Bio, Inc.
Via Business Wire
Tickers
ACET
![](https://mms.businesswire.com/media/20231102190660/en/1339314/22/adicet_logo_500x300_%28002%29_%28004%29.jpg)
![](https://mms.businesswire.com/media/20231031612979/en/1339314/22/adicet_logo_500x300_%28002%29_%28004%29.jpg)
![](https://mms.businesswire.com/media/20231004175869/en/1339314/22/adicet_logo_500x300_%28002%29_%28004%29.jpg)
Adicet Bio Announces Poster Presentation at the Upcoming 2023 Molecular Targets and Cancer Therapeutics Conference
October 04, 2023
From Adicet Bio, Inc.
Via Business Wire
Tickers
ACET
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.